共 142 条
[11]
Munnich A(2008)Complications in patients after intravitreal injection of bevacizumab Acta Ophthalmol 86 372-243
[12]
Israel A(2016)Systemic safety of intravitreal anti-vascular endothelial growth factor agents in age-related macular degeneration Curr Opin Ophthalmol 27 224-114
[13]
Heiss NS(2015)Two cases of acute abdomen after an intravitreal injection of bevacizumab Case Rep Ophthalmol 6 110-e76
[14]
Klauck SM(2015)Aortoduodenal fistula in a patient on intravitreal bevacizumab injections: a case report Am J Ther 22 e75-36
[15]
Kioschis P(2016)Vascular endothelial growth factor plasma levels before and after treatment of retinopathy of prematurity with ranibizumab Graefes Arch Clin Exp Ophthalmol 254 31-333
[16]
Berlin AL(2012)Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity Am J Ophthalmol 153 327-e20153218
[17]
Paller AS(2016)Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity PEDIATRICS 137 e20153218-65
[18]
Chan LS(2018)Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity J Aapos 22 61-286
[19]
O'Doherty M(2018)Comparing alternative Ranibizumab dosages for safety and efficacy in retinopathy of prematurity: a randomized clinical trial JAMA Pediatr 172 278-18
[20]
Mc Creery K(2018)Necrotizing enterocolitis: pathophysiology from a historical context Semin Pediatr Surg 27 11-561